Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

DOI: 10.5402/2012/159568

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text